(Q35641618)

9 August 2017

1 reference

title

Antiangiogenic therapy and tumor progression (English)

1 reference

9 August 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

1

Mikhail V Blagosklonny

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

13-17

1 reference

Multilineage embryonic hematopoiesis requires hypoxic ARNT activity

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Anoxic induction of ATF-4 through HIF-1-independent pathways of protein stabilization in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Oncogenic resistance to growth-limiting conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Out of air is not out of action

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Targeting gene expression to hypoxic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Perspectives on the development of a molecularly targeted agent

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Angiogenesis and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

HIF-1 as a target for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

How oxygen makes its presence felt

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

A cancer therapy resistant to resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Angiogenesis inhibitors and hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Choice of hormonal therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

HIF hydroxylation and the mammalian oxygen-sensing pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

HIF-1 and tumor progression: pathophysiology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Angiogenesis inhibitors: motivators of metastasis?

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Expression of hypoxia-inducible factor 1? in brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900336-2

7 January 2021

10.1016/S1535-6108(03)00336-2

Identifiers

DOI

1 reference

9 August 2017

1 reference